DelveInsight’s “Adult Myopia Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Adult Myopia, historical and forecasted epidemiology as well as the Adult Myopia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Adult Myopia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adult Myopia Market Forecast
Some of the key facts of the Adult Myopia Market Report:
The Adult Myopia market size is anticipated to grow with a significant CAGR during the study period (2022-2036).
Myopia and high myopia are projected to show a significant increase in prevalence globally, affecting nearly 5 billion people and 1 billion people, respectively, by 2050.
Average progression rates demonstrated a gradual decline with advancing age; however, the most substantial and clinically significant myopia progression was observed between 20 and 30 years of age.
The prevalence of myopia ranges between 1% and 78.4% across studies reported in the 21st century. Although myopia is more prevalent in East Asia, global prevalence has increased from 1.4 billion in 2000 and is projected to reach 4.8 billion by 2050.
Myopia progression is likely to continue into early adulthood. At age 18, although nearly 75% of myopes are stable, around 25% continue progressing, and approximately 20% of individuals in their 20s may experience progression of at least 1 diopter (D).
According to WHO-based prevalence projections, myopia and high myopia are expected to affect 52% (4.9 billion) and 10% (925 million) of the global population, respectively, by 2050, representing a major increase from 2010 estimates of 27% (1.9 billion) and 2.8% (170 million), respectively.
Key Adult Myopia Companies: Novartis, Regeneron Pharmaceuticals, and others
Key Adult Myopia Therapies: LUCENTIS, EYLEA, and others
The Adult Myopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Adult Myopia pipeline products will significantly revolutionize the Adult Myopia market dynamics.
Adult Myopia Overview
Adult Myopia is a common refractive eye disorder in which distant objects appear blurry while near objects remain clear. It occurs when the eyeball is elongated or the cornea is excessively curved, causing light rays to focus in front of the retina rather than directly on it. Although myopia often develops during childhood, it can continue to progress or emerge in adulthood due to genetic factors, prolonged near-work activities, and increased digital screen exposure.
Get a Free sample for the Adult Myopia Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/adult-myopia-market
Adult Myopia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Adult Myopia Epidemiology Segmentation:
The Adult Myopia market report proffers epidemiological analysis for the study period 2022–2036 in the 7MM segmented into:
Total Prevalent Population of Adult Myopia
Prevalence of Myopic Choroidal Neovascularization
Download the report to understand which factors are driving Adult Myopia epidemiology trends @ Adult Myopia Epidemiology Forecast
Adult Myopia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adult Myopia market or expected to get launched during the study period. The analysis covers Adult Myopia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Adult Myopia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Adult Myopia Therapies and Key Companies
LUCENTIS: Novartis
EYLEA: Regeneron Pharmaceuticals
Discover more about therapies set to grab major Adult Myopia market share @ Adult Myopia Treatment Landscape
Adult Myopia Market Drivers
Rising Prevalence of Myopia Worldwide: Increasing rates of myopia among adults, particularly in urban populations, are driving demand for vision correction and myopia management solutions.
Growing Digital Screen Usage: Prolonged use of smartphones, computers, and digital devices is contributing to eye strain and myopia progression, increasing the need for treatment options.
Increasing Awareness of Vision Health: Greater awareness regarding the long-term complications of high myopia is encouraging early diagnosis and treatment.
Advancements in Myopia Management Technologies: Innovations in contact lenses, spectacle lenses, refractive surgery, and pharmaceutical interventions are expanding treatment choices for adult patients.
Adult Myopia Market Barriers
High Cost of Advanced Treatment Options: Premium contact lenses, refractive surgeries, and specialized myopia management therapies may be unaffordable for some patients.
Limited Awareness in Certain Regions: Lack of awareness regarding myopia progression and associated complications can delay diagnosis and treatment.
Variability in Treatment Outcomes: Individual differences in disease progression and response to treatment may affect the effectiveness of available therapies.
Reimbursement Challenges: Many myopia management products and procedures may not be fully covered by insurance or reimbursement programs.
Scope of the Adult Myopia Market Report
Study Period: 2022–2036
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Adult Myopia Companies: Novartis, Regeneron Pharmaceuticals, and others
Key Adult Myopia Therapies: LUCENTIS, EYLEA, and others
Adult Myopia Therapeutic Assessment: Adult Myopia current marketed and Adult Myopia emerging therapies
Adult Myopia Market Dynamics: Adult Myopia market drivers and Adult Myopia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Adult Myopia Unmet Needs, KOL’s views, Analyst’s views, Adult Myopia Market Access and Reimbursement
To know more about Adult Myopia companies working in the treatment market, visit @ Adult Myopia Clinical Trials and Therapeutic Assessment
Table of Contents
1. Adult Myopia Market Report Introduction
2. Executive Summary for Adult Myopia
3. SWOT analysis of Adult Myopia
4. Adult Myopia Patient Share (%) Overview at a Glance
5. Adult Myopia Market Overview at a Glance
6. Adult Myopia Disease Background and Overview
7. Adult Myopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Adult Myopia
9. Adult Myopia Current Treatment and Medical Practices
10. Adult Myopia Unmet Needs
11. Adult Myopia Emerging Therapies
12. Adult Myopia Market Outlook
13. Country-Wise Adult Myopia Market Analysis (2022–2036)
14. Adult Myopia Market Access and Reimbursement of Therapies
15. Adult Myopia Market Drivers
16. Adult Myopia Market Barriers
17. Adult Myopia Appendix
18. Adult Myopia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/
Country: United States
Website: https://www.delveinsight.com/
